Cargando…
Smartphone measurements of physical activity and fitness are associated with early trial discontinuation of patients in (hemato)oncology phase I/II clinical trials
BACKGROUND: Patients, who discontinue early, do not benefit from phase I/II clinical trials (early-phase clinical trials (EPCT)). In this study, associations between objective smartphone measurements of physical activity and fitness and early trial discontinuation in patients with cancer participati...
Autores principales: | Douma, Joeri A. J., Zweegman, Sonja, Alberts, Mieke, Kruyswijk, Sandy, van de Donk, Niels C. W. J., van Linde, Myra, Buffart, Laurien M., Verheul, Henk M. W. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8163675/ https://www.ncbi.nlm.nih.gov/pubmed/33236210 http://dx.doi.org/10.1007/s00520-020-05902-2 |
Ejemplares similares
-
Feasibility, validity and reliability of objective smartphone measurements of physical activity and fitness in patients with cancer
por: Douma, Joeri A. J., et al.
Publicado: (2018) -
Clinical Predictors of Early Trial Discontinuation for Patients Participating in Phase I Clinical Trials in Oncology
por: Douma, Joeri A. J., et al.
Publicado: (2021) -
T-cell redirecting bispecific antibodies targeting BCMA for the treatment of multiple myeloma
por: Verkleij, Christie P.M., et al.
Publicado: (2020) -
Current and New Therapeutic Strategies for Relapsed and Refractory Multiple Myeloma: An Update
por: Nijhof, Inger S., et al.
Publicado: (2017) -
Hemato-oncología pediátrica
Publicado: (2006)